Core Viewpoint - The personal care products sector experienced a decline of 1.72% on January 15, with a notable drop in the stock of Wanjian Medical, while the overall market showed mixed results with the Shanghai Composite Index down 0.33% and the Shenzhen Component Index up 0.41% [1] Group 1: Market Performance - The personal care products sector's decline was led by Wanjian Medical, which fell by 3.57% to a closing price of 38.08 [2] - The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1] Group 2: Individual Stock Performance - Notable stock performances included: - Dengkang Oral (001328) rose by 2.51% to 41.27 with a trading volume of 28,300 shares and a transaction value of 116 million [1] - Other stocks such as Zhongshun Jierou (002511) and Liangmian Needle (600249) saw minor declines of 0.24% and 0.51% respectively [1] - The largest decline was observed in Wanjian Medical (300888), which dropped by 3.57% [2] Group 3: Capital Flow - The personal care products sector saw a net inflow of 531,700 yuan from institutional investors, while retail investors experienced a net outflow of 2,407,430 yuan [2] - The capital flow for individual stocks indicated that Wanjian Medical had a net inflow of 21,931,300 yuan from institutional investors, but a significant outflow of 45,204,800 yuan from retail investors [3]

Group 1 - The core viewpoint of the news is that Beijia Clean has shown significant stock performance and financial growth, with a notable increase in revenue and net profit year-on-year [1][2]. - As of January 15, Beijia Clean's stock price decreased by 2.02% to 35.42 CNY per share, with a total market capitalization of 3.558 billion CNY [1]. - The company has experienced a stock price increase of 17.75% year-to-date, with a 5-day increase of 11.14% and a 20-day increase of 15.07% [1]. Group 2 - For the period from January to September 2025, Beijia Clean achieved a revenue of 1.119 billion CNY, representing a year-on-year growth of 18.75%, and a net profit of 77.0674 million CNY, which is an increase of 84.58% compared to the previous year [2]. - The company has distributed a total of 115 million CNY in dividends since its A-share listing, with 46.145 million CNY distributed over the past three years [3]. - As of September 30, the number of shareholders increased to 9,788, a rise of 104.47%, while the average number of circulating shares per person decreased by 51.09% to 10,262 shares [2].

Core Viewpoint - The personal care products sector experienced a slight increase of 0.2% on January 14, with Baiya Co., Ltd. leading the gains, while the Shanghai Composite Index fell by 0.31% and the Shenzhen Component Index rose by 0.56% [1]. Group 1: Market Performance - The closing price of Baiya Co., Ltd. was 21.24, with an increase of 1.09% and a trading volume of 77,000 shares, amounting to a transaction value of 163 million yuan [1]. - Other notable performers included Yiyi Co., Ltd. with a closing price of 28.72 and a rise of 1.06%, and Haoyue Care with a closing price of 32.78 and an increase of 1.02% [1]. - Conversely, companies like Jiya Co., Ltd. and Wanjian Medical saw slight declines of 0.19% and 0.23%, respectively [1]. Group 2: Capital Flow - The personal care products sector saw a net inflow of 4.32 million yuan from institutional investors, while retail investors experienced a net outflow of 7.12 million yuan [2]. - The capital flow data indicates that Yiyi Co., Ltd. had a significant net inflow of 13.31 million yuan from institutional investors, while it faced a net outflow of 6.19 million yuan from retail investors [3]. - Other companies like Haoyue Care and Dongkang Oral also showed mixed capital flows, with institutional inflows but retail outflows [3].

Market Overview - The personal care products sector experienced a slight decline of 0.03% on January 13, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4138.76, down 0.64%, while the Shenzhen Component Index closed at 14169.4, down 1.37% [1] Stock Performance - Notable gainers in the personal care sector included: - Dengkang Oral Care (001328) with a closing price of 40.60, up 6.17% [1] - Beijia Clean (603059) with a closing price of 36.25, up 3.93% [1] - Jieya Co., Ltd. (301108) with a closing price of 35.95, up 3.72% [1] - Other stocks showed mixed performance, with some experiencing declines, such as: - Two-Sided Needle (600249) down 0.67% to 5.92 [1] - Zhongshun Jiesang (002511) down 0.95% to 8.32 [1] Capital Flow - The personal care products sector saw a net inflow of 17.19 million yuan from institutional investors, while retail investors experienced a net outflow of 20.21 million yuan [2] - The capital flow for individual stocks indicated that: - Reliable Co., Ltd. (301009) had a net inflow of 10.73 million yuan from institutional investors [3] - Beijia Clean (603059) faced a net outflow of 3.99 million yuan from institutional investors [3]

Company and Industry Summary Company Overview - The company reported a revenue of 1.119 billion yuan for the first half of 2025, representing a year-on-year growth of 19% [2] - Profit for the same period was 77 million yuan, showing an impressive year-on-year increase of 85% [2] - The probiotic business generated 50 million yuan in revenue, with a year-on-year growth of 82%, marking a significant turnaround from previous losses [4][3] Probiotic Market Insights - The probiotic market in China has experienced rapid growth, with a compound annual growth rate (CAGR) of 12.4% from 2018 to 2023, and is expected to reach a market size of 140 billion yuan by 2025 [6] - The food and beverage sector accounts for 67% of the market share, while dietary supplements hold 19%, with the latter showing significant growth [6] - Domestic companies are gradually achieving local replacements in the industrialization of emerging strains like AKK [6] AKK Product Development - The AKK product line from the subsidiary, Shanenkang, has a significantly higher gross margin compared to traditional products, contributing to an increase in the company's net profit margin to 16%-17% [7] - The company anticipates a further increase in profitability with the expansion of AKK production capacity expected in mid-2026 [7] - Major health brands such as WonderLab and Inner Health have launched corresponding products, propelling AKK into a phase of explosive growth [7] Marketing and Operational Changes - The rise of AI-driven marketing strategies is reshaping traffic distribution, significantly impacting marketing and channel companies [9] - E-commerce businesses have begun utilizing AR technology to enhance marketing efficiency [9] - Companies like RuYuchen, ShuiYang, and QingMu are expected to benefit from these changes [9] Revenue Growth Projections - The company's core business is projected to maintain stable growth around 10%, driven by categories like toothpaste and dental floss [10] - Revenue growth is expected to reach approximately 15% in 2026 and 2027 [10] - Net profit forecasts for 2025, 2026, and 2027 are 100 million, 130 million, and 170 million yuan, respectively [3][10] Industry Trends - The probiotic segment is a crucial part of China's health supplement industry, with the vitamin and dietary supplement market estimated at 200-300 billion yuan [11] - The GMV for probiotics on platforms like Douyin was around 6 billion yuan in 2025, with a year-on-year growth exceeding 30% [11] - Emerging brands such as WuKa Lab have rapidly gained market share, with GMV reaching approximately 800 million yuan [11] - The AKK strain, known for its metabolic benefits, is gaining international attention, evidenced by Danone's acquisition of an AKK producer for an estimated 150-250 million USD [11] Impact of Generated Engine Optimization (GEO) - GEO is a strategy aimed at enhancing content visibility in AI tools, potentially replacing traditional SEO [12] - Leading operational companies are adapting to this shift, with firms like YiWangYiChuang already making strides in AI applications [13] - Companies with strong e-commerce experience are likely to benefit from this transformation, with RuYuchen recommended as a benchmark due to its core probiotic product growth and adaptability to GEO opportunities [13]

Macroeconomic Insights - The US unemployment rate fell to 4.4% in December, down from a revised 4.5% in November, indicating a temporary halt in concerns over job market deterioration[11] - The US manufacturing PMI declined while the services PMI increased, reflecting mixed economic signals[7] - Consumer confidence in the US continued to recover in January, with inflation expectations slightly rising[7] Market Trends - Risk assets generally rose in the week of January 2-9, 2026, with major economies' stock markets and commodity prices increasing[7] - The 10-year US Treasury yield rose by 5.7%, while domestic 10Y government bond futures prices fell by 0.1%[7] - The dollar index increased by 0.7%, with the USD/CNY exchange rate at 6.98, indicating a slight appreciation of the yuan[7] Sector Performance - The AI application sector is expected to see significant growth, with a projected compound annual growth rate (CAGR) of over 35% for the AI industry and over 63% for the large model market[23] - The consumer electronics sector, particularly smart glasses, is experiencing rapid growth, with a projected 110% year-on-year increase in global shipments in the first half of 2025[38] Investment Recommendations - It is advised to overweight A/H shares due to multiple factors supporting Chinese equity performance, including an expected expansion of the fiscal deficit and a more aggressive economic policy[18] - Gold is recommended for overweight allocation due to its strong resilience and safe-haven attributes amid rising geopolitical uncertainties[20] - The report suggests a cautious approach to oil investments, recommending a lower allocation due to expected price pressures from geopolitical events and US policy directions[20]

公 司 研 究 股票研究 /[Table_Date] 2026.01.09 2026-01-12 主业稳健，益生菌贡献新增长点 倍加洁(603059) | [Table_Finance] 财务摘要(百万元) | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入 | 1,067 | 1,299 | 1,511 | 1,729 | 1,966 | | (+/-)% | 1.6% | 21.8% | 16.3% | 14.5% | 13.7% | | 净利润(归母) | 93 | -77 | 99 | 132 | 174 | | (+/-)% | -4.9% | -183.6% | 228.4% | 33.4% | 31.3% | | 每股净收益(元) | 0.92 | -0.77 | 0.99 | 1.32 | 1.73 | | 净资产收益率(%) | 7.4% | -7.8% | 9.2% | 11.1% | 12.8% | | 市盈率(现价&最新股本摊薄) | 34.43 | — | 32 ...

Market Overview - The personal care products sector increased by 1.28% on January 12, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 4165.29, up by 1.09%, while the Shenzhen Component Index closed at 14366.91, up by 1.75% [1] Stock Performance - Beijia (603059) closed at 34.88, with a rise of 10.00% and a trading volume of 21,500 lots, resulting in a transaction value of 74.26 million yuan [1] - Haoyue Care (605009) closed at 32.52, up by 2.59%, with a trading volume of 38,600 lots and a transaction value of 124 million yuan [1] - Reliable Co. (301009) closed at 13.11, increasing by 1.55%, with a trading volume of 47,100 lots and a transaction value of 61.36 million yuan [1] - Other notable stocks include: - Wenjian Medical (300888) at 39.73, up by 1.43% [1] - Runben Co. (603193) at 25.33, up by 1.40% [1] - Liangmian Needle (600249) at 5.96, up by 1.36% [1] Capital Flow - The personal care products sector experienced a net outflow of 1.1334 million yuan from institutional investors, while retail investors saw a net inflow of 5.4803 million yuan [2] - The overall capital flow indicates that while institutional investors withdrew funds, retail investors were actively buying into the sector [2] Detailed Capital Flow Analysis - Beijia (603059) had a net inflow of 23.84 million yuan from institutional investors, but a net outflow of 9.50 million yuan from speculative funds [3] - Haoyue Care (605009) saw a net inflow of 18.45 million yuan from institutional investors, with a net outflow of 12.29 million yuan from speculative funds [3] - Reliable Co. (301009) experienced a net outflow of 5.92 million yuan from institutional investors, while retail investors contributed a net inflow of 6.46 million yuan [3]

国泰海通晨报 2026 年 01 月 12 日 国泰海通证券股份有限公司 研究所 [汤蔚翔 Table_Authors] (分析师) 电话：021-38676172 邮箱：tangweixiang@gtht.com 登记编号：S0880511010007 [Table_ImportantInfo] 今日重点推荐 021-38038433 hanchaohui@gtht.com S0880523110001 张剑宇(研究助理) 021-38674711 zhangjianyu@gtht.com S0880124030031 梁中华(分析师) 021-23219820 liangzhonghua@gtht.com 宏观快报点评：《核心通胀韧性仍在》2026-01-09 12 月 CPI 同比增速+0.8%，环比+0.2%；PPI 同比增速-1.9%，环比回升至 0.2%。12 月通胀保持稳 步回升。食品价格低基数是 CPI 的主要贡献，核心通胀环比依然处于季节性上沿，同比维持稳定 （+1.2%）。12 月的金价重拾涨势是核心通胀维持韧性的关键，但中长期回升依然需要居民资产负债 表的持续修复。PPI 环比在 12 ...

Market Overview - The personal care products sector increased by 0.64% on January 9, with Dengkang Oral leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with Dengkang Oral closing at 39.19, up 1.79% on a trading volume of 15,000 shares and a transaction value of 58.84 million yuan [1] - Other notable performers included: - Zhongshun Jierou at 8.38, up 1.09%, with a trading volume of 164,500 shares and a transaction value of 137 million yuan [1] - Wanjian Medical at 39.17, up 1.03%, with a transaction value of 166 million yuan [1] - Liangmian Needle at 5.88, up 1.03%, with a trading volume of 119,500 shares and a transaction value of 69.76 million yuan [1] Capital Flow - The personal care products sector experienced a net outflow of 9.1265 million yuan from institutional investors and 14.5833 million yuan from speculative funds, while retail investors saw a net inflow of 23.7098 million yuan [2] - Detailed capital flow for specific stocks included: - Runben Co. with a net inflow of 4.5229 million yuan from institutional investors, but a net outflow of 6.0816 million yuan from speculative funds [3] - Yiyi Co. had a net outflow of 51,000 yuan from institutional investors, but a net inflow of 619.27 million yuan from retail investors [3] - Dengkang Oral saw a net outflow of 1.5334 million yuan from institutional investors [3]